Amezinium metilsulfate
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | C01CA25 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 30578-37-1 |
PubChem (CID) | 71926 |
ChemSpider | 64937 |
UNII | 03NR868ICX |
KEGG | D01304 |
ChEMBL | CHEMBL2106667 |
Chemical and physical data | |
Formula | C12H15N3O5S |
Molar mass | 313.32 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.[1][2]
References
- ↑ Araújo, D; Caramona, MM; Osswald, W (1983). "On the mechanism of action of amezinium methylsulphate on the dog saphenous vein". European Journal of Pharmacology. 90 (2–3): 203–14. doi:10.1016/0014-2999(83)90238-8. PMID 6873182.
- ↑ Lenke, D.; Gries, J.; Kretzschmar, R. (1981). "Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action". Arzneimittel-Forschung. 31 (9a): 1558–1565. PMID 7197970.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.